Cogent Biosciences (COGT) EPS (Basic): 2017-2020
Historic EPS (Basic) for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$8.61.
- Cogent Biosciences' EPS (Basic) fell 12400.00% to -$8.61 in Q4 2020 from the same period last year, while for Dec 2020 it was -$15.44, marking a year-over-year decrease of 595.50%. This contributed to the annual value of -$16.17 for FY2020, which is 286.84% down from last year.
- Cogent Biosciences' EPS (Basic) amounted to -$8.61 in Q4 2020, which was down 69.82% from -$5.07 recorded in Q3 2020.
- In the past 5 years, Cogent Biosciences' EPS (Basic) registered a high of $0.07 during Q4 2019, and its lowest value of -$8.61 during Q4 2020.
- Over the past 3 years, Cogent Biosciences' median EPS (Basic) value was -$0.53 (recorded in 2018), while the average stood at -$1.61.
- In the last 5 years, Cogent Biosciences' EPS (Basic) spiked by 124.14% in 2019 and then crashed by 12,400.00% in 2020.
- Quarterly analysis of 4 years shows Cogent Biosciences' EPS (Basic) stood at -$0.66 in 2017, then soared by 56.06% to -$0.29 in 2018, then soared by 124.14% to $0.07 in 2019, then tumbled by 12,400.00% to -$8.61 in 2020.
- Its last three reported values are -$8.61 in Q4 2020, -$5.07 for Q3 2020, and -$0.95 during Q2 2020.